| Summary: | Columbianadin (CBN) is one of the main bioactive constituents isolated from the root of <i>Angelica pubescens.</i> Although the anti-inflammatory activity of CBN has been reported, the underpinning mechanism of this remains unclear. In this study, we investigated the anti-inflammatory effect of CBN on lipopolysaccharide (LPS)-stimulated THP-1 cells and explored the possible underlying molecular mechanisms. The results showed that CBN suppressed LPS-mediated inflammatory response mainly through the inactivation of the NOD1 and NF-<inline-formula> <math display="inline"> <semantics> <mi mathvariant="sans-serif">κ</mi> </semantics> </math> </inline-formula>B p65 signaling pathways. Knockdown of NOD1 reduced the degree to which inflammatory cytokines decreased following CBN treatment, whereas forced expression of NOD1 and CBN treatment reduced NF-<inline-formula> <math display="inline"> <semantics> <mi mathvariant="sans-serif">κ</mi> </semantics> </math> </inline-formula>B p65 activation and the secretion of inflammatory cytokines. Furthermore, CBN significantly reduced cellular apoptosis by inhibiting the NOD1 pathway. Collectively, our results indicate that CBN suppressed the LPS-mediated inflammatory response by inhibiting NOD1/NF-<inline-formula> <math display="inline"> <semantics> <mi mathvariant="sans-serif">κ</mi> </semantics> </math> </inline-formula>B activation. Further investigations are required to determine the mechanisms of action of CBN in the inhibition of NOD signaling: However, CBN may be employed as a therapeutic agent for multiple inflammatory diseases.
|
|---|